Navigation Links
WuXi PharmaTech Provides Update of 2013 Financial Guidance, to Present at J.P. Morgan Healthcare Conference
Date:1/10/2014

SHANGHAI, Jan. 10, 2014 /PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development services company, with operations in China and the United States, today announced that it updated its 2013 financial guidance. The company expects to achieve total revenues for full-year 2013 of approximately $578 million. The company expects diluted EPS for full-year 2013 to slightly exceed the top end of its previous guidance of $1.51-$1.55 (GAAP) and $1.73-$1.77 (non-GAAP). These preliminary 2013 results are unaudited and remain subject to the finalization of the company's year-end closing, reporting, and audit processes. The company plans to report its fourth-quarter and full-year 2013 financial results and to provide 2014 financial guidance in March 2014.

The company also announced that it will present at the 32th annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2014 at 8:30 a.m. Pacific Standard Time. The company's slides from the conference will be available on the company's Investor Relations page at www.wuxiapptec.com.

For more information, please contact:

Ronald Aldridge (for investors)
Director, Investor Relations
Tel: +1-201-585-2048
Email: ir@wuxiapptec.com

Aaron Shi (for the media)
Assistant Director, Corporate Communications
Tel: +86-21-5046-4362
Email: pr@wuxiapptec.com

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not historical facts, bu
'/>"/>

SOURCE WuXi PharmaTech
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Winners of WuXi PharmaTech Awards Inducted into Prestigious Academies
2. WuXi PharmaTech Presents 2013 Life Science and Chemistry Awards
3. WuXi PharmaTech to Partner with Pharmacyclics
4. WuXi PharmaTech Announces Third-Quarter 2013 Results
5. WuXi PharmaTech Announces Licensing Agreement for Patient-Derived Xenograft Models with Mayo Clinics Center for Individualized Medicine
6. Zacks.com featured expert Kevin Matras highlights: Core Laboratories NV, Invesco Ltd., Medtronic, Inc., Willbros Group Inc. and WuXi PharmaTech Inc.
7. WuXi PharmaTech Schedules First-Quarter 2013 Earnings Release
8. Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules
9. WuXi PharmaTech Receives Letter from AAALAC Commending Animal Care at Suzhou Toxicology Facility as "Exemplary"
10. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
11. WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014 Decision Resources Group finds ... the U.S. Food and Drug Administration,s (FDA) approval of ... Velphoro, which was approved by the FDA in November ... disease (CKD) patients on dialysis. Other key ... (US) Q2 2014 : ...
(Date:1/15/2014)... 2014  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced ... Global Industry Analysis, Size, Share, Growth, Trends And Forecast, ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) ... patients in order to treat dental impairments, for tooth ...
(Date:1/15/2014)... (the "Company") (NASDAQ: CLSN ) today announced ... purchase an aggregate of approximately $15 million of the ... led by a dedicated health care fund. ... investors pursuant to which the Company agreed to sell ...
Breaking Medicine Technology:Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
... The End of Polio Concert, funded by the ... 2011, in Perth Australia, has resulted in an unprecedented ... The highly publicized and critically acclaimed concert, which ... Polio Eradication Initiative, has resulted in contributions of $50 ...
... Conn., Nov. 7, 2011 Planet Biopharmaceuticals, Inc. and ... specialty pharmaceutical company focused on providing products for allergy ... an asset sale of ALLERGY CONTROL PRODUCTS, INC., a ... Jersey limited liability company. Theron E. Odlaug, ...
Cached Medicine Technology:Pioneering Gift From the Sumner M. Redstone Foundation Leads to $118 Million Multi-Country Commitment to End Polio 2Pioneering Gift From the Sumner M. Redstone Foundation Leads to $118 Million Multi-Country Commitment to End Polio 3Pioneering Gift From the Sumner M. Redstone Foundation Leads to $118 Million Multi-Country Commitment to End Polio 4
(Date:7/13/2014)... Max International has recently ... be the featured guest at its Charity Exhibition and ... Attendees will learn about Max’s health products and ... basketball games and perform in a 3 point shoot-out. ... and energy-boosting supplements , has recently announced former NBA ...
(Date:7/13/2014)... 13, 2014 A decreased ability to identify ... and Alzheimer,s disease, while examinations of the eye ... associated with Alzheimer,s, in the brain, according to ... at the Alzheimer,s Association International Conference 2014 (AAIC ... studies, the decreased ability to identify odors was ...
(Date:7/13/2014)... Seattle, WA (PRWEB) July 13, 2014 ... Ken Woolcott, who commented, “As a parent of a ... the underserved need in the Seattle community for contemporary ... will provide an important alternative to students and families ... the best practices and environment for special education. We ...
(Date:7/13/2014)... July 13, 2014 Recently, iFitDress.com, one ... women’s special occasion outfits, has added a new selection ... Furthermore, the company has launched a promotion for these ... , iFitDress.com is now providing thousands of graceful ... sell well in Britain, America, France, Italy and many ...
(Date:7/12/2014)... 12, 2014 The Passenger Information System ... 2013 to $20,341.36 million by 2019, at an expected ... 2019. , The public transport infrastructure in North America ... available in almost every corner of the region. The ... of public transport service providers are driving the North ...
Breaking Medicine News(10 mins):Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 2Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 3Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 4Health News:Smell and eye tests show potential to detect Alzheimer's early 2Health News:Smell and eye tests show potential to detect Alzheimer's early 3Health News:Smell and eye tests show potential to detect Alzheimer's early 4Health News:Smell and eye tests show potential to detect Alzheimer's early 5Health News:Smell and eye tests show potential to detect Alzheimer's early 6Health News:Smell and eye tests show potential to detect Alzheimer's early 7Health News:New Private School, Emerald City School, Founded in Downtown Seattle Now Accepting 1st to 6th Grade Students Who Learn Differently 2Health News:New and Beautiful Evening Dresses Unveiled by iFitDress.com 2Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 4
... survey conducted by India's National Family Health Survey, half the ... 200,000 people and is the third one since 1992-1993. ... infant mortality in rural areas is 62% while it is ... while in China it is only 8%. On the nutrition ...
... Ministry of Health of the Government of Southern Sudan reported ... 8 out of 10 states of Southern// Sudan. ... a total of 79 suspected cases including 8 deaths were ... disaggregated population data are leading to difficulties in determining whether ...
... exercise improves the physical and psychological wellbeing of people affected// ... most common cancer among women in the UK. Treatment for ... of life. ,Current cancer rehabilitation programs are ... consider the physical problems faced by patients. ...
... before bedtime, could make you sleep quicker,// says a new ... University of Sydney studied 12 healthy men who were 18-35 ... cooked rice in their meals - plain rice, long-grain rice ... Jasmine rice has a high glycemic index - a ranking ...
... In patients with recently diagnosed multiple sclerosis, the extent ... as determined by magnetic resonance imaging (MRI) may predict ... valuable information about the progression of multiple sclerosis (MS), ... used to monitor the number and volume of MS-related ...
... at the nation’s colleges of osteopathic medicine is projected ... 45.3 percent increase since 2002-03. ,With ... of Health Sciences, in Mesa, Arizona; the Debusk College ... Tennessee; and the TOURO College of Osteopathic Medicine in ...
Cached Medicine News:Health News:Exercise Benefits Breast Cancer Patients 2Health News:Extent of Brain Involvement at Diagnosis May Predict Brain Atrophy 2Health News:Osteopathic Medical Education Will Help With Shortages 2
... Maximum Xtra, and Maximum ACT introducers ... and specialty hemostasis introducers in the ... premier hemostasis introducers for use in ... angiography, angioplasty, stenting, atherectomy, temporary pacing, ...
St. Jude Medical's line of guiding introducers includes Swartz Series, SAFL, SEPT, CSTA, RAMP, and 2 piece steerable...
The intended use of the percutaneous PREFACE Guiding Sheath is for the introduction of intravascular electrophysiology catheters into any cardiac chamber....
... EP Systems sells the popular transeptal ... needles. These products allow left atrial ... catheter ablation of left-sided arrhythmogenic substrates. ... others use it when a transaortic ...
Medicine Products: